About the Editors

Editor-in-Chief

Alan D.T. Barrett, PhD
Director, Sealy Institute for Vaccine Sciences
University of Texas Medical Branch
TX, USA  


Alan D.T. Barrett obtained his B.S., M.S. and PhD in the area of virology from the University of Warwick, followed by a post-doctoral fellowship in arbovirology at the London School of Hygiene and Tropical Medicine. As a leading expert in the fields of vaccine development for flaviviruses, his lab undertakes basic research and preclinical development for vaccines against various flavivirus diseases. He has made several contributions to World Health Organization activities on vaccine research, development and implementation. He is a member of the Scientific Advisory Committee, Coalition for Epidemic Preparedness Innovations (CEPI) that is developing vaccines for Ebola, Nipah, Lassa fever and MERS, the flavivirus vaccine working group of the CDC Advisory Committee on Immunization Practices and has served on many NIH study sections.

Deputy Editor

Rick TitballRick Titball, PhD, DSc
Professor of Molecular Microbiology
University of Exeter
Exeter, UK


Rick Titball's principal interests lie with understanding the molecular basis of disease caused by a range of bacterial pathogens. His previous work has involved extensive studies on biothreat agents. He has a strong interest in using information on the molecular biology of pathogens to devise vaccines and have previously developed vaccines against Yersinia pestis and Clostridium perfringens toxins.

Associate Editors

Paul A. MacAry, PhD
Director, LSI Immunology Programme 
National University of Singapore
Singapore, Singapore


Associate Professor Paul MacAry performed his post-doctoral research at Cambridge University Institute for Medical Research (CIMR), and since 2005 has been an independent investigator in the Department of Microbiology and Immunology program at the National University of Singapore (NUS). The multi-disciplinary research in his laboratory covers the entire spectrum of scientific endeavour, from basic research to industrial applications with an emphasis on antibody biology, immune repertoire mapping and protein engineering applications in infectious diseases. 

Richard Rupp, MD
Department of Pediatrics
University of Texas Medical Branch
TX, USA
 

Richard Rupp is the Director of the Clinical Trials Program of the Sealy Institute for Vaccine Sciences at the University of Texas Medical Branch at Galveston. He is a Professor and the Director of the Division of Adolescent and Behavioral Health within the Department of Pediatrics. He received his M.D. from Saint Louis University School of Medicine. He completed Pediatric Residency and Adolescent Medicine Fellowship in Texas at Wilford Hall Medical Center and William Beaumont AMC, respectively.

Veronika von Messling, Dr. med. vet. 
Director General, Life Sciences
Federal Ministry of Education and Research
Berlin, Germany


Prof.  Dr. von Messling's research interest lies in characterizing the pathogenesis of respiratory viruses to develop novel prophylactic and therapeutic strategies. She has been awarded various awards and prizes such as the Chercheur-boursier senior Award, FRSQ, (2011), and the Löffler-Frosch Prize, German Society of Virology (2011). She is also a member of various societies such as the European Society of Virology, Canadian Society of Microbiology and Deutsche virologische Gesellschaft.

David H. Walker, MD, PhD
Department of Pathology
University of Texas Medical Branch
TX, USA


David Walker is the Director of the Center for Biodefense and Emerging Infectious Diseases. His research has elucidated mechanisms of immunity to Rickettsia and Ehrlichia, developed animal models for investigating rickettsioses and ehrlichioses and contributed to elucidating the pathology and pathophysiology of Lassa fever, Rocky Mountain spotted fever, Mediterranean spotted fever and human monocytotropic ehrlichiosis. 

Advisory Editor

CClaudio Nunes-Alvesláudio Nunes-Alves
Cláudio studied biochemistry at the University of Porto, Portugal, before earning his Ph.D. in Life and Health Sciences. He shared his time between Portugal and the United States, in the laboratories of Margarida Correia-Neves (at the Life and Health Sciences Research Institute, Braga, Portugal), Sam Behar (then at the Brigham and Women's Hospital, Boston, Massachusetts, USA) and Christophe Benoist (at Harvard Medical School, Boston, Massachusetts, USA), studying multiple aspects of immunity to tuberculosis. These included clarifying the role of CD8+ T cells following Mycobacterium tuberculosis challenge and how infection of the thymus affects ongoing immunity to tuberculosis. After a brief postdoctoral position with Sam Behar at the University of Massachusetts Medical School, USA, Cláudio joined the Nature Reviews Microbiology team as an Associate Editor in April 2014 and after a successful period as locum Chief Editor in 2015, he became a Senior Editor. Cláudio joined the Nature Microbiology team in March 2016. Cláudio became Advisory Editor for npj Vaccines in July 2021.

Editorial Board Members

L. Garry Adams: Texas A&M College Station, Texas, USA
Sylvie Alonso: National University of Singapore, Singapore
Carl R. Alving: Walter Reed Army Institute of Research, Silver Spring, Maryland, USA
Peter L. Andersen: Statens Serum Institute, Copenhagen, Denmar
Bernard Arulanandam: University of Texas at San Antonio, Texas, US
David W. C. Beasley: University of Texas Medical Branch, Texas, USA
Martin Beer: Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany
David I. Bernstein: Cincinnati Children's Hospital Medical Center, Ohio, USA
Paul L. Bigliardi: University of Minnesota, Minnesota, USA
Danny Casimiro: Sanofi Pasteur, Pennsylvania, USA
Ashok K. Chopra: University of Texas Medical Branch, Texas, USA
James Crowe: Vanderbilt University, Tennessee, USA
Denise Doolan: James Cook University, Australia, Cairns, Australia
J. Stephen Dumler: Uniformed Services University for the Health Sciences, Maryland, USA
Janice Endsley: University of Texas Medical Branch, Texas, USA
Susanna Esposito: Università degli Studi di Milano, Milan, Italy
Ali I. Fattom: NanoBio Corporation, Michigan, USA
Thomas Ficht: Texas A&M University, Texas, USA
Katja Fink: Humabs BioMed SA, Bellinzona, Switzerland
Anthony R. Fooks: Animal and Plant Health Agency (APHA), Surrey, UK
Alexander Freiberg: University of Texas Medical Branch, Texas, USA
Tong-Ming Fu: Sanofi Pasteur, Massachusetts, USA
Michael Gale, Jr.: University of Washington, Washington, USA
Adolfo Garcia-Sastre: Mount Sinai School of Medicine, New York, USA
Nathalie Garcon: Bioaster Technology Research Institute, Brussels, Belgium
Nisha J. Garg: University of Texas Medical Branch, Texas, USA
Sarah Gilbert: Jenner Institute, University of Oxford, Oxford, UK
Jaap Goudsmit: University of Amsterdam, Amsterdam, Netherlands
Barney S. Graham: NIH, Maryland, USA
Beth-Ann Griswold Coller: Merck Research Laboratories, New Jersey, USA
Joachim Hombach: World Health Organization, Geneva, Switzerland
Tetsuro Ikegami: University of Texas Medical Branch, Texas, USA
Ken J. Ishii: Osaka University, Osaka, Japan
Nicholas Jackson: Coalition for Epidemic Preparedness Innovations (CEPI), London, UK
Kathrin Jansen: Pfizer Vaccine Research, New York, USA
Stefan Kappe: Seattle Biomedical Research Institute, Washington, USA
David C. Kaslow: ATH, Seattle, Washington, USA
Stephen Kent: University of Melbourne, Melbourne, Australia
Janine Kimpel: Medical University of Innsbruck, Innsbruck, Australia
Dennis M. Klinman: National Cancer Institute, NIH, Maryland, USA
Eiji Konishi: Osaka University, Osaka, Japan
Margaret Liu: Karolinska Institute, Stockholm, Sweden
Shan Lu: University of Massachusetts Medical School, Massachusetts, USA
Mary Marovich:  National Institute of Allergy and Infectious Diseases, NIH, Maryland, USA
Peter Mason: Regeneron Pharmaceuticals, Tarrytown, New York, USA
Jere W. McBride: University of Texas Medical Branch, Texas, USA
Philip Minor: National Institute for Biological Standards and Control, Potters Bar, UK
Thomas P. Monath: Crozet BioPharma, Massachusetts, USA
Kathleen M. Neuzil: University of Maryland School of Medicine, Maryland, USA
Walter Orenstein: Emory University, Georgia, USA
Slobodan Paessler: University of Texas Medical Branch, Texas, USA
Guy H. Palmer: Washington State University, Washington, USA
Daniel Paris: Mahidol Oxford Research Unit, Bangkok, Thailand
Kevin Pethe: Nanyang Technological University, Singapore
Stanley Plotkin: University of Pennsylvania, Vaxconsult, Pennsylvania, USA
Maarten Postma: University of Groningen, Groningen, Netherlands
Bali Pulendran: Stanford University, California, USA
Cheng-Feng Qin: Beijing Institute of Microbiology and Epidemiology, Beijing, China
Rino Rappuoli: GSK Vaccines, Siena, Italy
Steven G. Reed: Infectious Diseases Research Institute, Washington, USA
Guus Rimmelzwaan: University of Veterinary Medicine, Center for Emerging Infections and Zoonoses, Hanover, Germany
Jai Rudra: Washington University in St. Louis, Missouri, USA
Robert Sauerwein: Radboud University Medical Center, Nijmegen, Netherlands
Alexander Schmidt: Bill and Melinda Gates Foundation, Massachusetts, USA
Alessandro Sette: La Jolla Institute for Allergy and Immunology, California, USA
Pei-Yong Shi: University of Texas Medical Branch, Texas, USA
John Shiver: Sanofi-Pasteur Vaccines, Swiftwater, Pennsylvania, USA
Mark K. Slifka: Oregon Health & Science University, Oregon, USA
Jon Smith: VLP Therapeutics, Maryland, USA
Lynn Soong: University of Texas Medical Branch, Texas, USA
J. Erin Staples: Centers for Disease Control, Colorado, USA
Geraldine Taylor: Pirbright Institute, Woking, UK
Dirk Teuwen: Union Chimique Belge (UCB), Brussels, Belgium
Ralph A. Tripp: The UGA college of Veterinary Medicine, Georgia, USA
Takafumi Tsuboi: Ehime University, Ehime, Japan
Sylvia van den Hurk: University of Saskatchewan, Saskatchewan, Canada
Kirsten Vannice: Consultant, Washington, USA
Hengliang Wang: Beijing Institute of Biotechnology, Beijing, China
Scott C. Weaver: University of Texas Medical Branch, Texas, USA
David B. Weiner: University of Pennsylvania, Pennsylvania, USA
Fidel Zavala: ohn Hopkins Bloomberg School of Public Health, Maryland, USA
Qinjian Zhao: Xiamen University, Xiamen, Fujian, China